Drug Type Small molecule drug |
Synonyms HSK 39297, HSK39297 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glomerulonephritis, IGA | Phase 2 | CN | 12 Oct 2024 | |
Hemoglobinuria, Paroxysmal | Phase 2 | CN | 17 Jul 2024 | |
C3 glomerulopathy | Phase 1 | CN | 25 Dec 2023 | |
Idiopathic Membranous Glomerulonephritis | Phase 1 | CN | 25 Dec 2023 | |
Lupus Nephritis | Phase 1 | CN | 25 Dec 2023 | |
Glomerular disease | IND Application | CN | 12 Oct 2023 |